Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase NEDD4 is an enzyme encoded by the human *NEDD4* gene. It is a founding member of the HECT domain-containing family of E3 ubiquitin ligases. The primary function is to catalyze the transfer of ubiquitin from an E2 conjugating enzyme to specific substrate proteins—most notably various ion channels and membrane receptors—marking them for endocytosis and proteasomal degradation. Through these actions, it regulates key cellular processes including signal transduction pathways (such as insulin-like growth factor signaling), neuronal architecture during brain development, receptor downregulation (including EGFR family members), bone formation/remodeling, viral budding mechanisms for several viruses via matrix protein modification, among others. Dysregulation has been implicated in cancer progression—where it can promote tumorigenesis by degrading tumor suppressor substrates—as well as developmental disorders affecting neural tissues and mineralized tissues like bone and teeth.
Drugs or molecules targeting NEDD4 typically act by inhibiting its E3 ligase activity, thereby preventing the ubiquitination and subsequent degradation or endocytosis of its substrate proteins. This can modulate pathways involved in cell proliferation, survival, or receptor signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase NEDD4 (NEDD4).